Description

Three companies (Solara Active Pharma Sciences, Bombay Burmah Trading Corporation, and Capital India Finance) clarified to BSE that they have disclosed all material information and have no undisclosed price-sensitive information regarding recent volume spikes in their securities.

Summary

BSE received clarifications from three companies in response to surveillance queries about significant increases in trading volumes of their securities. Solara Active Pharma Sciences Limited, The Bombay Burmah Trading Corporation Limited, and Capital India Finance Limited each confirmed that they have made all required disclosures under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Regulation 30, and have not withheld any material or price-sensitive information that would affect price/volume behavior.

Key Points

  • Solara Active Pharma Sciences (Scrip Code: Not mentioned) confirmed compliance with Regulation 30 and stated no material information has been withheld
  • Bombay Burmah Trading Corporation (Scrip Code: 501425) stated they do not know the reasons for the volume increase and have no undisclosed price-sensitive information
  • Capital India Finance Limited (Scrip Codes: 530879, 976963) confirmed consistent compliance with listing regulations and timely disclosure of all events affecting operations/performance
  • All three companies responded to BSE Surveillance queries dated December 4, 2025
  • Reference numbers: L/SURV/ONL/PV/APJ/2025-2026/735 (Solara), /733 (Bombay Burmah), /734 (Capital India Finance)

Regulatory Changes

No regulatory changes announced. This circular contains routine compliance clarifications in response to exchange surveillance activity.

Compliance Requirements

  • Companies must respond to BSE surveillance queries regarding unusual volume movements
  • Companies must confirm whether all material information has been disclosed per Regulation 30 of SEBI LODR 2015
  • Companies must state if any undisclosed price-sensitive information exists that could affect share price/volume behavior
  • Responses must be submitted by authorized company secretary or compliance officer

Important Dates

  • December 4, 2025: Date of BSE surveillance queries and company responses

Impact Assessment

Minimal market impact. These are standard surveillance clarifications where companies confirm regulatory compliance and absence of undisclosed material information. The volume increases mentioned appear to be market-driven rather than related to corporate developments. No new information disclosed that would affect trading or investor decisions. This is routine exchange surveillance activity to ensure market integrity.

Impact Justification

Routine surveillance clarifications confirming no undisclosed material information; no actual price-sensitive developments or regulatory violations disclosed